Autonomix Ebitda from 2010 to 2024

AMIX Stock   3.35  0.18  5.10%   
Autonomix Medical, EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Autonomix Medical, EBITDA regression line of annual values had significance of  0.01 and arithmetic mean of (1,515,321). View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-15.3 M
Current Value
-14.5 M
Quarterly Volatility
5.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Autonomix Medical, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autonomix Medical,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 77 K, Interest Expense of 79.2 K or Selling General Administrative of 5.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.04. Autonomix financial statements analysis is a perfect complement when working with Autonomix Medical, Valuation or Volatility modules.
  
Check out the analysis of Autonomix Medical, Correlation against competitors.

Latest Autonomix Medical,'s Ebitda Growth Pattern

Below is the plot of the Ebitda of Autonomix Medical, Common over the last few years. It is Autonomix Medical,'s EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Autonomix Medical,'s overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Autonomix Ebitda Regression Statistics

Arithmetic Mean(1,515,321)
Coefficient Of Variation(361.32)
Mean Deviation3,628,429
Median752,447
Standard Deviation5,475,218
Sample Variance30T
Range16M
R-Value(0.63)
Mean Square Error19.4T
R-Squared0.40
Significance0.01
Slope(773,612)
Total Sum of Squares419.7T

Autonomix Ebitda History

2024-14.5 M
2023-15.3 M
2022-2 M

About Autonomix Medical, Financial Statements

Autonomix Medical, investors use historical fundamental indicators, such as Autonomix Medical,'s Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Autonomix Medical,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-15.3 M-14.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Autonomix Stock Analysis

When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.